Antimicrobial discovery inspired by ecological interactions

被引:46
作者
Molloy, Evelyn M. [1 ]
Hertweck, Christian [1 ,2 ]
机构
[1] Leibniz Inst Nat Prod Res & Infect Biol HKI, Dept Biomol Chem, Beutenbergstr 11A, D-07745 Jena, Germany
[2] Friedrich Schiller Univ, Nat Prod Chem, D-07743 Jena, Germany
关键词
PATHOGEN PAENIBACILLUS-LARVAE; NATURAL-PRODUCTS; PYXIDICOCCUS-FALLAX; DRUG DISCOVERY; ANTIBIOTICS; BACTERIA; MICROBIOME; BIOSYNTHESIS; MYXOBACTERIA; METABOLITES;
D O I
10.1016/j.mib.2017.09.006
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Bacteria represent an unparalleled source of antibiotics used to treat infectious diseases. Yet, genome analyses have revealed that their full biosynthetic potential is much larger than expected. Valuable strategies to unearth hidden antibiotics are genome mining, pathway engineering and triggering, as well as co-cultivation approaches. Nevertheless, there is growing understanding that it is often essential to consider the ecological context and that there is a great potential for antimicrobial discovery from bacteria engaged in well-defined interactions with other organisms. Various ecological scenarios involving antimicrobial agents are outlined in this review: predator prey and pathogenic interactions, the protection of insect assets such as offspring and cultivars, as well as host protection in symbiotic relationships with plants, invertebrates and animals/humans. The illustrative examples given reinforce the idea that examination of interactions between organisms can yield new antimicrobial compounds, and ultimately further our understanding of the function of these molecules in the environment.
引用
收藏
页码:121 / 127
页数:7
相关论文
共 60 条
  • [1] Adnani N, 2017, NAT PROD REP
  • [2] Cystobactamids: Myxobacterial Topoisomerase Inhibitors Exhibiting Potent Antibacterial Activity
    Baumann, Sascha
    Herrmann, Jennifer
    Raju, Ritesh
    Steinmetz, Heinrich
    Mohr, Kathrin I.
    Huettel, Stephan
    Harmrolfs, Kirsten
    Stadler, Marc
    Mueller, Rolf
    [J]. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION, 2014, 53 (52) : 14605 - 14609
  • [3] Macrotermycins A-D, Glycosylated Macrolactams from a Termite-Associated Amycolatopsis sp M39
    Beemelmanns, Christine
    Ramadhar, Timothy R.
    Kim, Ki Hyun
    Klassen, Jonathan L.
    Cao, Shugeng
    Wyche, Thomas P.
    Hou, Yanpeng
    Poulsen, Michael
    Bugni, Tim S.
    Currie, Cameron R.
    Clardy, Jon
    [J]. ORGANIC LETTERS, 2017, 19 (05) : 1000 - 1003
  • [4] Natural products from microbes associated with insects
    Beemelmanns, Christine
    Guo, Huijuan
    Rischer, Maja
    Poulsen, Michael
    [J]. BEILSTEIN JOURNAL OF ORGANIC CHEMISTRY, 2016, 12 : 314 - 327
  • [5] Metabolite induction via microorganism co-culture: A potential way to enhance chemical diversity for drug discovery
    Bertrand, Samuel
    Bohni, Nadine
    Schnee, Sylvain
    Schumpp, Olivier
    Gindro, Katia
    Wolfender, Jean-Luc
    [J]. BIOTECHNOLOGY ADVANCES, 2014, 32 (06) : 1180 - 1204
  • [6] Antibacterial drug discovery in the resistance era
    Brown, Eric D.
    Wright, Gerard D.
    [J]. NATURE, 2016, 529 (7586) : 336 - 343
  • [7] Bioactive natural products from novel microbial sources
    Challinor, Victoria L.
    Bode, Helge B.
    [J]. ANTIMICROBIAL THERAPEUTICS REVIEWS, 2015, 1354 : 82 - 97
  • [8] Cheng B, 2017, ANGEW CHEM INT ED
  • [9] Bacteriocins - a viable alternative to antibiotics?
    Cotter, Paul D.
    Ross, R. Paul
    Hill, Colin
    [J]. NATURE REVIEWS MICROBIOLOGY, 2013, 11 (02) : 95 - 105
  • [10] Daly KM, 2012, CURR PROTEIN PEPT SC, V13, P509